GlassScriptPhysician profile
Brian R Weston
NPI 1316144405
$1,712.03
in general payments reported to CMS, 2019-2025
8 companies · $33.65 in 2025
The $33.65 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $58.93 · 2021: $132 · 2022: $506 · 2023: $463 · 2024: $363 · 2025: $33.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $859.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,094.65 | 2019-2025 | Extractor Pro Rx, Exalt Model D, Resolution 360 Clip |
| Olympus America INC. | $182.61 | 2020-2024 | Endoclot Phs, Visiglide |
| Micro-Tech Endoscopy USA, INC. | $127.53 | 2024 | Eyemax |
| Cook Medical LLC | $96.97 | 2024 | Fusion |
| Conmed Corporation | $90.25 | 2023-2024 | Conmed Dilation, Conmed Hemostasis, Conmed Generators |
| Alkermes, INC. | $83.96 | 2023 | Vivitrol |
| Medtronic, INC. | $19.60 | 2025 | Nexpowder |
| Pentax of America, INC. | $16.46 | 2023 | N/A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Weston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.